Table 1.
|
|
By first event |
||
---|---|---|---|---|
All patients ( N = 490) | Discharge ( n = 235) | Cardiac arrest ( n = 63) | Limitation in life support ( n = 192) | |
Age |
52 (42 to 62) |
48 (40 to 59) |
50 (41 to 63) |
56 (48 to 66) |
Female |
43.5 |
46.0 |
41.3 |
41.1 |
Nonwhite |
40.8 |
39.2 |
46.0 |
41.2 |
Oncology comorbidity |
18.4 |
15 |
17 |
22 |
Charlson Comorbidity Index |
2 (1 to 4) |
1 (0 to 3) |
3 (1 to 5) |
3 (1 to 4) |
Functional Comorbidity Index |
1 (1 to 3) |
1 (1 to 3) |
1 (0 to 3) |
1 (1 to 3) |
Study site hospital |
|
|
|
|
1 |
38.0 |
31.9 |
42.9 |
43.8 |
2 |
31.0 |
31.9 |
33.3 |
29.2 |
3 |
31.0 |
36.2 |
23.8 |
27.1 |
Days in hospital before ALI onset |
2 (1 to 6) |
2 (1 to 5) |
2 (1 to 10) |
3 (1 to 7) |
Medical ICU |
80.4 |
74.9 |
84.1 |
85.9 |
APACHE II score at ICU admission |
26 (20 to 33) |
23 (19 to 29) |
33 (22 to 38) |
29 (22 to 35) |
SOFA score at ALI onset |
9 (7 to 12) |
8 (5 to 10) |
12 (8 to 14) |
11 (8 to 14) |
Survival to ICU discharge | 56.3 | 100.0 | 23.8 | 13.5 |
Data presented as median (interquartile range) or percentage. ALI, Acute lung injury; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.